Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Immunostaining revealed mixed cell populations with many undifferentiated hPSCs and mesoderm cells, and DE markers SOX17 and FOXA2 were expressed at lower levels compared to the Activin A-based control (CA)
This review aims to propose innovative diagnostic and therapeutic approaches for CNS diseases and enhance drug design for more effective delivery across the BBB
Yamada, Y
Combining the deep foundational lifting of Ultherapy with the advanced dermal tightening of XERF creates an unmatched lifting synergy
US$ 26.09
US$ 27.66
US$ 23.97
US$ 22.59
US$ 22.23
